zingerone has been researched along with Diabetic Nephropathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, Y; Cui, Y; Hua, Q; Liu, Y; Shi, Y; Wang, S | 1 |
Ahmad, B; Ahmad, SB; Bhat, SA; Ganaie, MA; Madkhali, H; Majid, S; Rashid, SM; Rasool, S; Rehman, MU; Shakeel, S | 1 |
2 other study(ies) available for zingerone and Diabetic Nephropathies
Article | Year |
---|---|
Zingerone attenuates diabetic nephropathy through inhibition of nicotinamide adenine dinucleotide phosphate oxidase 4.
Topics: Animals; Cell Death; Collagen Type IV; Diabetic Nephropathies; Down-Regulation; Fibronectins; Glucose; Guaiacol; Humans; Inflammation; Kidney Tubules, Proximal; Lipids; Mice, Inbred C57BL; NADPH Oxidase 4; Oxidative Stress; Protective Agents; Up-Regulation | 2018 |
Zingerone (4-(4-hydroxy-3-methylphenyl)butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Gene Expression Regulation; Guaiacol; Inflammation; Kidney Function Tests; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Respiratory Burst; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |